Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2013 by Fudan University.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Ye Guo, Fudan University
ClinicalTrials.gov Identifier:
NCT01333605
First received: April 11, 2011
Last updated: March 2, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)